Neuronetics STIM
$ 1.03
-3.74%
Quarterly report 2024-Q2
added 08-12-2024
Neuronetics Balance Sheet 2011-2024 | STIM
Annual Balance Sheet Neuronetics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-46.7 M | -58.1 M | -13.7 M | -44.6 M | -74.2 M | 409 K | 3.1 M | - | - | - | - | - |
Long Term Debt |
22.8 M | 35.3 M | 34.6 M | 19.9 M | 30.4 M | 29.6 M | 15.6 M | - | - | - | - | - |
Long Term Debt Current |
824 K | 670 K | 594 K | 559 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 24.6 M | 32.4 M | 220 M | 189 M | - | - | - | - | - |
Total Current Liabilities |
33.2 M | 15.7 M | 13.7 M | 27.7 M | 13.6 M | - | - | - | - | - | - | - |
Total Liabilities |
59.8 M | 56 M | 53.2 M | 52.3 M | 46 M | 232 M | 202 M | - | - | - | - | - |
Deferred Revenue |
1.98 M | 2.5 M | 2.02 M | 2.23 M | 2.26 M | 1.97 M | 1.33 M | - | - | - | - | - |
Retained Earnings |
-346 M | -309 M | -278 M | -250 M | -221 M | -197 M | -181 M | - | - | - | - | - |
Total Assets |
117 M | 141 M | 78.7 M | 100 M | 117 M | 38.9 M | 24.8 M | - | - | - | - | - |
Cash and Cash Equivalents |
70.3 M | 94.1 M | 49 M | 75.7 M | 105 M | 29.1 M | 17 M | - | - | - | - | - |
Book Value |
57.1 M | 85.2 M | 25.5 M | 47.9 M | 71 M | -193 M | -177 M | - | - | - | - | - |
Total Shareholders Equity |
57.1 M | 85.2 M | 25.5 M | 47.9 M | 71 M | -193 M | -177 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Neuronetics
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
46.1 M | 59.4 M | 59.3 M | 36.9 M | 36.7 M | 36.6 M | 22.8 M | 27 M | - | 35.4 M | 35.3 M | 35.1 M | 34.9 M | 34.8 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 29.6 M | 29.6 M | 29.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
77.4 M | 76.2 M | 81.6 M | 55 M | 54.9 M | 55.3 M | 59.8 M | 56.2 M | - | 53.3 M | 56 M | 52 M | 50.9 M | 50.3 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 52.3 M | 52.3 M | 52.3 M | 52.3 M | 46 M | 46 M | 46 M | 46 M | 44.5 M | 44.5 M | 44.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
1.45 M | 1.62 M | 1.62 M | 1.64 M | 1.67 M | 1.89 M | 1.98 M | 1.73 M | - | 1.91 M | 2.5 M | 1.87 M | 1.94 M | 1.91 M | 2.02 M | 2.02 M | 2.02 M | 2.02 M | 2.23 M | 2.23 M | 2.23 M | 2.23 M | 2.26 M | 2.26 M | 2.26 M | 2.26 M | 1.97 M | 1.97 M | 1.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-394 M | -384 M | -376 M | -371 M | -361 M | -356 M | -346 M | -338 M | - | -320 M | -309 M | -301 M | -293 M | -285 M | -278 M | -278 M | -278 M | -278 M | -250 M | -250 M | -250 M | -250 M | -221 M | -221 M | -221 M | -221 M | -197 M | -197 M | -197 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
96.8 M | 104 M | 116 M | 93 M | 100 M | 104 M | 117 M | 119 M | - | 130 M | 141 M | 143 M | 148 M | 152 M | 78.7 M | 78.7 M | 78.7 M | 78.7 M | 100 M | 100 M | 100 M | 100 M | 117 M | 117 M | 117 M | 117 M | 38.9 M | 38.9 M | 38.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
42.6 M | 47.7 M | 59.7 M | 35.8 M | 45.9 M | 55.4 M | 70.3 M | 73.7 M | 70.9 M | 80.8 M | 94.1 M | 99.4 M | 116 M | 121 M | 49 M | 49 M | 49 M | 49 M | 75.7 M | 75.7 M | 75.7 M | 75.7 M | 105 M | 105 M | 105 M | 105 M | 29.1 M | 29.1 M | 29.1 M | - | 17 M | - | - | - | 21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
19.4 M | 27.7 M | 34.2 M | 37.9 M | 45.5 M | 48.3 M | 57.1 M | 63 M | - | 76.6 M | 85.2 M | 91.1 M | 97.2 M | 102 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 47.9 M | 47.9 M | 47.9 M | 47.9 M | 71 M | 71 M | 71 M | 71 M | -5.52 M | -5.52 M | -5.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
19.4 M | 27.7 M | 34.2 M | 37.9 M | 45.5 M | 48.3 M | 57.1 M | 63 M | 68.4 M | 76.6 M | 85.2 M | 91.1 M | 97.2 M | 102 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 47.9 M | 47.9 M | 47.9 M | 47.9 M | 71 M | 71 M | 71 M | 71 M | -193 M | -193 M | -193 M | - | -177 M | - | - | - | -166 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency